Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Placebo-controlled Clinical Trial of Lactobacillus Helveticus as an add-on Strategy for the Treatment of Major Depression

NCT04333277 is registered in ClinicalTrials.gov with Federal University of Minas Gerais as lead sponsor.

NCT NCT04333277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Placebo-controlled Clinical Trial of Lactobacillus Helveticus as an add-on Strategy for the Treatment of Major Depression
Lead sponsor
Federal University of Minas Gerais
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2020
Completion date
April 30, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression